Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 13.

Weidner, C I; Lin, Q; Birkhofer, C; Gerstenmaier, U; Kaifie, A; Kirschner, M; Bruns, H; Balabanov, S; Trummer, A; Stockklausner, C; Höchsmann, B; Schrezenmeier, H; Wlodarski, M; Panse, J; Brümmendorf, T H; Beier, F; Wagner, W (2016). DNA methylation in PRDM8 is indicative for dyskeratosis congenita. OncoTarget, 7(10):10765-10772.

Ziegler, P; Boettcher, S; Takizawa, H; Manz, M G; Brümmendorf, T H (2016). LPS-stimulated human bone marrow stroma cells support myeloid cell development and progenitor cell maintenance. Annals of Hematology, 95(2):173-178.

Werner, B; Beier, F; Hummel, S; Balabanov, S; Lassay, L; Orlikowsky, T; Dingli, D; Brümmendorf, T H; Traulsen, A (2015). Reconstructing the in vivo dynamics of hematopoietic stem cells from telomere length distributions. eLife, 4:e08687.

Ummanni, R; Duscharla, D; Barett, C; Venz, S; Schlomm, T; Heinzer, H; Walther, R; Bokemeyer, C; Brümmendorf, T H; Murthy, P V; Balabanov, S (2015). Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Journal of Proteomics, 119:218-229.

Honecker, F; Rohlfing, T; Harder, S; Braig, M; Gillis, A J; Glaesener, S; Barett, C; Bokemeyer, C; Buck, F; Brümmendorf, T H; Looijenga, L H; Balabanov, S (2014). Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines. Journal of Proteomics, 96:300-313.

Braig, M; Pällmann, N; Preukschas, M; Steinemann, D; Hofmann, W; Gompf, A; Streichert, T; Braunschweig, T; Copland, M; Rudolph, K L; Bokemeyer, C; Koschmieder, S; Schuppert, A; Balabanov, S; Brümmendorf, T H (2014). A 'telomere-associated secretory phenotype' cooperates with BCR-ABL to drive malignant proliferation of leukemic cells. Leukemia, 28(10):2028-2039.

Balabanov, S; Braig, M; Brümmendorf, T H (2014). Current aspects in resistance against tyrosine kinase inhibitors in chronic myelogenous leukemia. Drug Discovery Today: Technologies, 11:89-99.

Sievert, H; Pällmann, N; Miller, K K; Hermanns-Borgmeyer, I; Venz, S; Sendoel, A; Preukschas, M; Schweizer, M; Boettcher, S; Janiesch, P C; Streichert, T; Walther, R; Hengartner, M O; Manz, M G; Brümmendorf, T H; Bokemeyer, C; Braig, M; Hauber, J; Duncan, K E; Balabanov, S (2014). A novel mouse model for inhibition of DOHH-mediated hypusine modification reveals a crucial function in embryonic development, proliferation and oncogenic transformation. Disease Models & Mechanisms, 7(8):963-976.

Balabanov, S; Wilhelm, T; Venz, S; Keller, G; Scharf, C; Pospisil, H; Braig, M; Barett, C; Bokemeyer, C; Walther, R; Brümmendorf, T H; Schuppert, A (2013). Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors. PLoS ONE, 8(1):e53668.

Ziegler, P; Chahoud, T; Wilhelm, T; Pällmann, N; Braig, M; Wiehle, V; Ziegler, S; Schröder, M; Meier, C; Kolodzik, A; Rarey, M; Panse, J; Hauber, J; Balabanov, S; Brümmendorf, T H (2012). Evaluation of deoxyhypusine synthase inhibitors targeting BCR-ABL positive leukemias. Investigational New Drugs, 30(6):2274-2283.

Sievert, H; Venz, S; Platas-Barradas, O; Dhople, V M; Schaletzky, M; Nagel, C H; Braig, M; Preukschas, M; Pällmann, N; Bokemeyer, C; Brümmendorf, T H; Pörtner, R; Walther, R; Duncan, K E; Hauber, J; Balabanov, S (2012). Protein-protein-interaction network organization of the hypusine modification system. Molecular & Cellular Proteomics, 11(11):1289-1305.

Ziegler, P; Schrezenmeier, H; Akkad, J; Brassat, U; Vankann, L; Panse, J; Wilop, S; Balabanov, S; Schwarz, K; Martens, U M; Brümmendorf, T H (2012). Telomere elongation and clinical response to androgen treatment in a patient with aplastic anemia and a heterozygous hTERT gene mutation. Annals of Hematology, 91(7):1115-1120.

Ummanni, R; Barreto, F; Venz, S; Scharf, C; Barett, C; Mannsperger, H A; Brase, J C; Kuner, R; Schlomm, T; Sauter, G; Sültmann, H; Korf, U; Bokemeyer, C; Walther, R; Brümmendorf, T H; Balabanov, S (2012). Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro. Journal of Proteome Research, 11(4):2452-2466.

This list was generated on Sat Sep 22 09:22:51 2018 CEST.